Register
Login:
Share:
Email Facebook Twitter

Fund Manager Chris Bailey talks about an opportunist 2017 for investors Watch here

Fund Manager Chris Bailey talks about an opportunist 2017 for investors


Sareum Share Chat (SAR)



Share Price: 0.875Bid: 0.85Ask: 0.90Change: 0.00 (0.00%)No Movement on Sareum
Spread: 0.05Spread as %: 5.88%Open: 0.875High: 0.875Low: 0.875Yesterday’s Close: 0.875


Share Discussion for Sareum


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


mangio61
Posts: 2,262
Off Topic
Opinion:No Opinion
Price:0.875
a friend
Today 10:58
has just pointed this to me....
http://www.bbc.co.uk/news/health-38611680
 
Mr_Jay
Posts: 1,589
Off Topic
Opinion:No Opinion
Price:0.875
RE: The
Today 10:23
Searle that's a great find! Up to 4.5p sounds great.
Searle
Posts: 149
Observation
Opinion:No Opinion
Price:0.875
View Thread (5)
The
Today 09:40
Hybridian note is out there on the link below. Apologies if already posted:
https://indigo.bluematrix.com/indigo/Viewer.action?info=kK07jdZm7EGz%2FWD2gYRctTo3RpFQsQDr

The key part as some have already posted:
"With Chk1 in good hands, Sareum is at liberty to focus on its other programmes
towards the clinic. In 2017, we expect the completion of pre-clinical work on
Aurora+FLT3, and progress on lead optimisation for TYK2, a novel programme
in the JAK inhibitor family. On a risked basis, we still see the shares as
significantly undervalued with the potential to double and on an un-risked
basis see the potential to unlock value up to a share price of circa 4.5p, should
its programmes progress up the development curve."
Utahsaints
Posts: 791
Off Topic
Opinion:No Opinion
Price:0.875
RE: Got
Today 09:37
Slow morning!
minden
Posts: 1,309
Off Topic
Opinion:No Opinion
Price:0.875
RE: Got
Today 08:22
Meant positive trading .
minden
Posts: 1,309
Off Topic
Opinion:No Opinion
Price:0.875
Got
Today 08:21
a feeling we'll have a good trading day. Good luck all,
tyche100
Posts: 1,133
Off Topic
Opinion:No Opinion
Price:0.875
RE: Heart-rendering story . . .
Today 08:19
http://www.newcastle-hospitals.org.uk/staff-profiles/15285.aspx

I'm from up this way, this tragic case has had lots of publicity on the local news, surely if the young lad is suitable they would have offered the trial? although I have no idea how thinks le this work.
ogm4
Posts: 290
Off Topic
Opinion:No Opinion
Price:0.875
RE: Patents TYK2
Today 05:34
The more I read about this share, the more excited I get. Some interesting posts over the weekend. Seems a lot of potential here.
Keep them coming guys. Thanks.
Thoth2
Posts: 1,216
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.875
RE: Patents TYK2
Sun 22:03
Boss. Specifically because if you look at the compound factsheet they test it against "tofa" which is tofacacitinib aka xeljianz. Which is a pfizer marketed drug. Why ? None of the other compounds are compared to competitors. If you look at adisinsight it has also been un preclinical trials in the uk in autoimmune. But our autoimmune partners are based in sanfrancisco (sri). Sometimes 2+2 =5. Sometimes is doesnt.
Thoth2
Posts: 1,216
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.875
View Thread (2)
RE: Re- Heart Rendering Story
Sun 21:57
Ruth plummer is in charge if the trials in newcastle which is closest. None of us are very intimate with the company unfortunately. Cruk and icr go on about lack of paediatric trials. And then they have the opportunity here and dont do it themselves.....




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.